Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Michel Perreault's main focus is the evaluation of psychiatric and substance abuse programs.  

Eric Latimer, PhD, is a health economist and looks for ways to improve the services to people with severe forms of mental illness.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Mimi Israël is active in eating disorders, affective disorders, crisis intervention, emergency psychiatry and mental health care service organization.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.  

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.